Reducing Time Delay in the Thrombolysis of Myocardial Infarction: An Internal Quality Improvement Project
- 1 May 2000
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Medical Quality
- Vol. 15 (3) , 85-93
- https://doi.org/10.1177/106286060001500302
Abstract
The objectives of this study were to improve thrombolytic therapy in acute myocardial infarction by reducing the "door-to-needle" time in a 285-bed university hospital in Spain. A quality management approach was used involving all the relevant staff. Target standard was set at 35 minutes. Baseline data, intervention effect, and continuous monitoring were analyzed using x control charts. Analysis of baseline data showed a wide out-of-control variation and 72 minutes' average delay. Cause analysis revealed organizational and clinical problems that were subjected to intervention. Postintervention data showed a stable process, with an average of 30 minutes. Continuous monitoring showed further improvement in average time and predictable variation. The template of the current control chart has an average of 26 minutes. Quality management methods, particularly staff involvement in problem analysis and intervention design, and the use of control charts were useful to understand, solve, and continuously monitor an important clinical problem whose existence was evident only after it was measured.Keywords
This publication has 23 references indexed in Scilit:
- The use of audit to set up a thrombolysis programme in the accident and emergency department.Emergency Medicine Journal, 1996
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- Time as an adjunctive agent to thrombolytic therapyJournal of Thrombosis and Thrombolysis, 1994
- Thrombolysis in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities Report from the Pre-hospital Study Group and the Cincinnati Heart ProjectAmerican Heart Journal, 1990
- Guidelines for the early management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1990
- Very early thrombolytic therapy in suspected acute myocardial infarctionThe American Journal of Cardiology, 1990
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Time from onset of symptoms to thrombolytic therapy: A major determinant of myocardial salvage in patients with acute transmural infarctionJournal of the American College of Cardiology, 1985